Pharmaron LLC
25 articles about Pharmaron LLC
-
CMS(00867) Joins Hands with Pharmaron to Promote the Singapore Manufacturing Plant Acquisition and CDMO Business in SEA
1/2/2024
PharmaGend Global Medical Services Pte. Ltd., jointly invested by China Medical System Holdings Limited, through its wholly-owned subsidiary CMS MEDICAL VENTURE PTE. LTD., and its non-wholly owned subsidiary Rxilient Health Pte. Ltd., with Pharmaron International Limited and Healthy Goal Limited, has entered into a lease agreement for the building and property located in Tuas, Singapore and completed the purchase of certain production machines and equipment from Strides Pharma Global Pte.
-
Pharmaron’s Liverpool UK Gene Therapy CDMO Commences Major Site Expansion Following UK Government Grant to Support £151m Investment
3/29/2023
Pharmaron Beijing Co., Limited announced that their Liverpool, UK based Gene Therapy CDMO has received a prestigious grant from the UK Government’s Life Sciences Innovation Manufacturing Fund to expand their viral vector and DNA manufacturing facilities for more than 8,000 sqM.
-
Pharmaron Acquires Commercial API Manufacturing Facility in the United States
5/24/2022
Pharmaron Beijing Co., Limited announced that it has entered into a definitive Asset Purchase Agreement to acquire the Coventry API manufacturing site in the United States from Noramco.
-
Pharmaron Appoints Dr. Antony Davies as Senior Vice President, UK CMC
1/17/2022
Pharmaron Beijing Co., Limited announced the appointment of Dr. Antony Davies as Senior Vice President, UK CMC, effective January 10, 2022.
-
Pharmaron Acquires Commercial API Manufacturing Facility in the United Kingdom from Recipharm
1/10/2022
Pharmaron Beijing Co., Limited announced that it has acquired Aesica Pharmaceuticals Limited from Recipharm group.
-
Pharmaron Appoints Dr. Sid Bhoopathy as Senior Vice President, US Head of Laboratory Services and CGT
1/7/2022
Pharmaron Beijing Co., Limited today announced the appointment of Dr. Sid Bhoopathy as Senior Vice President, US Head of Laboratory Services and CGT, effective November 1, 2021.
-
Beijing-based CRMO Pharmaron has accomplished impressive global growth via acquisitions over the past eight months.
-
Pharmaron Acquires Absorption Systems in the USA
11/9/2020
Pharmaron Beijing Co. announced that it has acquired 100% of the equity of Absorption Systems for up to US$137.5 million in cash.
-
Pharmaron LLC Acquires U.S. Phase I/II Clinical CRO From Shin Nippon Biomedical Laboratories
3/1/2017
-
Pharmaron LLC Acquires Majority Stake In SNBL Clinical Pharmacology Center
2/28/2017
-
Pharmaron LLC Release: CRO Acquires Xceleron
1/10/2017
-
Pharmaron LLC And Merck Sharp & Dohme Agree Deal To Acquire MSD’s UK Hoddesdon Site
9/26/2016
-
Pharmaron LLC Joins The NCI’s Chemical Biology Consortium To Fight Against Cancer
6/14/2016
-
Pharmaron LLC Acquires Quotient BioResearch
2/4/2016
-
Pharmaron LLC Receives A CFDA GLP Certificate For Its Safety Assessment Facility
12/16/2015
-
Pharmaron LLC Earns CFDA GLP Certification For Toxicology Facility
3/4/2014
-
AstraZeneca PLC Expands R&D in China to Boost Drug Discovery; Pharmaron LLC Will Add Hundreds of Scientists to Astra Team
10/15/2012
-
Update: Pharmaron LLC Continuing to Demonstrate its Leadership in GLP Toxicology Service Capabilities
11/4/2011
-
Pharmaron LLC to Host Merck Serono Research and Development Laboratory in China
9/14/2011
-
Pharmaron LLC Chooses Reaxys® To Enhance Productivity and Competitiveness
8/29/2011